Risk of Major Adverse Cardiovascular Events With Inhaled Anticholinergics in Patients With Chronic Obstructive Pulmonary Disease

被引：1
|
作者：
Kesten, Steven [1 ]
Leimer, Inge [1 ]
Jara, Michele [2 ]
机构：
[1] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
[2] Epidemiol Consulting, Danbury, CT USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2009年 / 301卷 / 12期
关键词：
TIOTROPIUM; TRIAL; COPD;
D O I：
10.1001/jama.2008.947
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1224 / 1224
页数：1
相关论文
共 50 条
  • [11] CHRONIC KIDNEY DISEASE LEADS TO ADVERSE CARDIOVASCULAR EVENTS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS USING INHALED LONG-ACTING BRONCHODILATORS
    Cheng, Yi-Ching
    Chen, Yen-Fu
    Chen, Chung-Yu
    RESPIROLOGY, 2018, 23 : 122 - 123
  • [12] Major comorbidities lead to the risk of adverse cardiovascular events in chronic obstructive pulmonary disease patients using inhaled long-acting bronchodilators: a case-control study
    Chen, Yen-Fu
    Cheng, Yi-Ching
    Chou, Chien-Hong
    Chen, Chung-Yu
    Yu, Chong-Jen
    BMC PULMONARY MEDICINE, 2019, 19 (01)
  • [13] Major comorbidities lead to the risk of adverse cardiovascular events in chronic obstructive pulmonary disease patients using inhaled long-acting bronchodilators: a case-control study
    Yen-Fu Chen
    Yi-Ching Cheng
    Chien-Hong Chou
    Chung-Yu Chen
    Chong-Jen Yu
    BMC Pulmonary Medicine, 19
  • [14] Risk of Cardiovascular Events Associated with Inhaled Corticosteroid Treatment in Patients with Chronic Obstructive Pulmonary Disease: A Meta-Analysis
    Jing, Xia
    Li, Yufeng
    Xu, Jianying
    CANADIAN RESPIRATORY JOURNAL, 2018, 2018
  • [15] Pulmonary Artery Stiffness by Cardiac Magnetic Resonance Imaging Predicts Major Adverse Cardiovascular Events in patients with Chronic Obstructive Pulmonary Disease
    Lucia Agoston-Coldea
    Silvia Lupu
    Teodora Mocan
    Scientific Reports, 8
  • [16] Pulmonary Artery Stiffness by Cardiac Magnetic Resonance Imaging Predicts Major Adverse Cardiovascular Events in patients with Chronic Obstructive Pulmonary Disease
    Agoston-Coldea, Lucia
    Lupu, Silvia
    Mocan, Teodora
    SCIENTIFIC REPORTS, 2018, 8
  • [17] Chronic obstructive pulmonary disease and cardiovascular events
    Villar Alvarez, Felipe
    de Miguel Diez, Javier
    Alvarez-Sala, Jose Luis
    ARCHIVOS DE BRONCONEUMOLOGIA, 2008, 44 (03): : 152 - 159
  • [18] Are there cardiovascular adverse effects of inhaled anticholinergics?
    Bela, Nagy Laszlo
    ORVOSI HETILAP, 2015, 156 (31) : 1246 - 1252
  • [19] Inhaled anticholinergics versus inhaled beta-mimetics in chronic obstructive pulmonary
    Lode, H
    INTERNIST, 1999, 40 (01): : 114 - 114
  • [20] CHA2DS2-VASc scores predict major adverse cardiovascular events in patients with chronic obstructive pulmonary disease
    Ooi, Hean
    Chen, Li-Hsiou
    Ni, Yung-Lun
    Shen, Huan-Ting
    Lee, Yen-Hsien
    Chu, Yi-Chun
    Fang, Ke-Chih
    Chen, I-Hung
    Hsu, Shu-Lan
    Chen, Hsing-Chun
    Huang, Chien-Hsiu
    Fan, Kuo-Sheng
    Lai, Chun-Liang
    Hang, Liang-Wen
    CLINICAL RESPIRATORY JOURNAL, 2018, 12 (03): : 1038 - 1045
12345